Chat with us, powered by LiveChat

First Large Case Series Regarding Stem Cell Reimplant Complications Published

POSTED ON IN Latest News BY Chris Centeno

pubmed_logo

We’re proud at Regenexx to announce the world’s first publication of a large, several year case series of patients treated with autologous mesenchymal stem cells and tracked prospectively for complications. The fact that no serious stem cell related complications were reported and the fact that the world’s highest definition MRI technology (3.0 Tesla imaging) was used to track more than 50 re-implant sites over time for tumor formation, makes this paper the first of it’s kind.  No other clinic around the globe or even pharma sponsored group has published on anywhere near this number of cases followed for anywhere near this length of time.  The upshot, cultured adult stem cells delivered through a needle for orthopedic applications in this large study were safer than the higher risk surgical procedures they helped many patients avoid.

    *DISCLAIMER: Like all medical procedures, Regenexx® Procedures have a success and failure rate. Patient reviews and testimonials on this site should not be interpreted as a statement on the effectiveness of our treatments for anyone else.
    Providers listed on the Regenexx website are for informational purposes only and are not a recommendation from Regenexx for a specific provider or a guarantee of the outcome of any treatment you receive.

    comments

    comments for this post are closed

    About the Author

    Chris Centeno

    Christopher J. Centeno, M.D. is an international expert and specialist in regenerative medicine and the clinical use of mesenchymal stem cells in orthopedics. He is board certified in physical medicine as well as rehabilitation and in pain management through The American Board of Physical Medicine and Rehabilitation.…

    View Profile

    Search Blog

    Categories